Next generation sequencing (NGS) panels and library preparation products for accurate detection of genetic variants 

SureSeq NGS

The application of next generation sequencing (NGS) technologies to cancer research in recent years has provided novel insights into disease initiation, progression and response to therapy. This powerful technique allows for accurate analysis of nucleotide-level aberrations such as single nucleotide variants (SNVs) and small insertions and deletions.

The SureSeq™ NGS product range includes customisable, pre-optimised NGS cancer panel content and pre-designed targeted sequencing panels for research into a wide range of cancer types and library preparation products for a streamlined NGS workflow.

Useful links


SureSeq™ and myPanel™: For research use only; not for use in diagnostic procedures.